Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Venkataraman, Arvind"" wg kryterium: Autor


Wyświetlanie 1-4 z 4
Tytuł :
Sex differences in immune responses that underlie COVID-19 disease outcomes.
Autorzy :
Takahashi T; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Ellingson MK; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Wong P; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Israelow B; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.
Lucas C; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Klein J; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Silva J; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Mao T; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Oh JE; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Tokuyama M; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Lu P; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Venkataraman A; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Park A; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Liu F; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.; Department of Biomedical Engineering, Yale School of Engineering & Applied Science, New Haven, CT, USA.
Meir A; Boyer Center for Molecular Medicine, Department of Microbial Pathogenesis, Yale University, New Haven, CT, USA.
Sun J; Department of Comparative Medicine, Yale University School of Medicine, New Haven, CT, USA.
Wang EY; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Casanovas-Massana A; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Wyllie AL; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Vogels CBF; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Earnest R; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Lapidus S; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Ott IM; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.; Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA.
Moore AJ; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Shaw A; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.
Fournier JB; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.
Odio CD; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.
Farhadian S; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.
Dela Cruz C; Department of Medicine, Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT, USA.
Grubaugh ND; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Schulz WL; Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA.; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.
Ring AM; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Ko AI; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Omer SB; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.; Yale Institute for Global Health, Yale University, New Haven, CT, USA.; Yale School of Nursing, Yale University, Orange, CT, USA.
Iwasaki A; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. .; Howard Hughes Medical Institute, Chevy Chase, MD, USA. .
Pokaż więcej
Corporate Authors :
Yale IMPACT Research Team
Źródło :
Nature [Nature] 2020 Dec; Vol. 588 (7837), pp. 315-320. Date of Electronic Publication: 2020 Aug 26.
Typ publikacji :
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Sex Characteristics*
COVID-19/*immunology
Cytokines/*immunology
Immunity, Innate/*immunology
SARS-CoV-2/*immunology
T-Lymphocytes/*immunology
COVID-19/blood ; COVID-19/virology ; Chemokines/blood ; Chemokines/immunology ; Cohort Studies ; Cytokines/blood ; Disease Progression ; Female ; Humans ; Lymphocyte Activation ; Male ; Monocytes/immunology ; Phenotype ; Prognosis ; RNA, Viral/analysis ; SARS-CoV-2/pathogenicity ; Viral Load
Czasopismo naukowe
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies